BNP Paribas Asset Management’s Ultragenyx Pharmaceutical RARE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $52.8M | Buy |
1,452,130
+301,674
| +26% | +$11M | 0.13% | 163 |
|
|
2025
Q1 | $41.7M | Buy |
1,150,456
+192,379
| +20% | +$6.97M | 0.11% | 196 |
|
|
2024
Q4 | $40.3M | Buy |
958,077
+233,895
| +32% | +$9.84M | 0.1% | 214 |
|
|
2024
Q3 | $40.2M | Sell |
724,182
-106,193
| -13% | -$5.9M | 0.1% | 209 |
|
|
2024
Q2 | $34.1M | Buy |
830,375
+323,280
| +64% | +$13.3M | 0.09% | 232 |
|
|
2024
Q1 | $23.7M | Buy |
507,095
+424,476
| +514% | +$19.8M | 0.06% | 281 |
|
|
2023
Q4 | $3.95M | Buy |
+82,619
| New | +$3.95M | 0.01% | 567 |
|
|
2022
Q3 | – | Sell |
-8,139
| Closed | -$486K | – | 959 |
|
|
2022
Q2 | $486K | Buy |
+8,139
| New | +$486K | ﹤0.01% | 849 |
|